Early intervention with guideline-based therapy for hepatorenal syndrome-acute kidney injury (HRS-AKI) is critical for reversing this life-threatening complication of advanced cirrhosis. However, keeping up to date with the latest clinical practice guidelines, emerging evidence, and expanding treatment options is challenging. Join us for part 2 of this two-part live national webinar series to: Explore real-world insights from a national survey of clinicians involved in HRS-AKI diagnosis and management Hear leading HRS-AKI experts discuss the latest evidence and treatment approaches for using vasoconstrictor therapy for HRS-AKI Engage in an interactive case-based discussion on individualizing treatment for patients with HRS-AKI Have your questions answered during a live Q&A session Access a downloadable HRS-AKI Diagnosis and Treatment Point-of-Care Guide for use in your clinical practice
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/rega2024-coc-1-identifying-overcoming-barriers-early-recognition-diagnosis
- Start Date: 2025-03-27 05:00:00
- End Date: 2025-03-27 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Mallinckrodt Pharmaceuticals - Amount: 61250.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all